Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01858883
Title Safety Study of INCB039110 in Combination With Gemcitabine and Nab-Paclitaxel in Subjects With Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Incyte Corporation
Indications

pancreatic adenocarcinoma

Advanced Solid Tumor

Therapies

Nab-paclitaxel

Filgrastim

Itacitinib

Gemcitabine

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Scottsdale Arizona United States Details
Fayetteville Arkansas United States Details
Beverly Hills California United States Details
Southington Connecticut United States Details
Indianapolis Indiana United States Details
Baltimore Maryland United States Details
Lake Success New York United States Details
Philadelphia Pennsylvania United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field